https://www.business-standard.com/article/companies/bharat-biotech-to-begin-trials-of-intranasal-vaccine-for-covid-in-feb-mar-121010800340_1.html
The Phase-1 trials will be conducted in Saint Louis University’s Vaccine and Treatment Evaluation Unit
Bharat Biotech to begin trials of intranasal vaccine for Covid in Feb-Mar
Published in Business and Uncategorized
More from BusinessMore posts in Business »
- Pound Sterling Price News and Forecast: GBP/USD slips despite strong UK Retail Sales as USD dominance prevails
- US Dollar climbs as trade rumors fuel market speculation
- US President Trump: We will be reasonable on tariffs
- Dow Jones dips as trade uncertainty lingers, consumer sentiment sinks
- USD/CAD holds firm as mixed trade headlines cloud USD outlook
- Research: When Leaders Express Positivity Early On, Employees Perform Better
- 7 AI Tools That Help You Build a One-Person Business — and Make Money While You Sleep
- Microsoft Created an Ad Using AI and No One Picked Up On It: ‘Saved 90% of the Time and Cost’
- This Quiet Shift Is Helping Founders Build Fierce Customer Loyalty
- Want to Boost Your Profits by Up to 95%? Focus on This Underrated Metric.
More from UncategorizedMore posts in Uncategorized »
- Pound Sterling Price News and Forecast: GBP/USD slips despite strong UK Retail Sales as USD dominance prevails
- US Dollar climbs as trade rumors fuel market speculation
- US President Trump: We will be reasonable on tariffs
- Dow Jones dips as trade uncertainty lingers, consumer sentiment sinks
- USD/CAD holds firm as mixed trade headlines cloud USD outlook
- Research: When Leaders Express Positivity Early On, Employees Perform Better
- 7 AI Tools That Help You Build a One-Person Business — and Make Money While You Sleep
- Microsoft Created an Ad Using AI and No One Picked Up On It: ‘Saved 90% of the Time and Cost’
- This Quiet Shift Is Helping Founders Build Fierce Customer Loyalty
- Want to Boost Your Profits by Up to 95%? Focus on This Underrated Metric.